Schering AG $180 mil. Medrad acquisition will provide combo contrast media/syringe offerings.
Executive Summary
SCHERING AG $180 MIL. MEDRAD BUY WILL PROVIDE COMBO CONTRAST MEDIA/SYRINGE product offerings, Medrad noted Aug. 23 in announcing the acquisition. Schering's position in the worldwide contrast media market "will be further strengthened by packaging [its] contrast media with Medrad's disposable syringes to create a simpler, more efficient administration system for customers," Medrad said.